Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Why The Hims & Hers Health Rally Has Room To Run
05:01pm, Friday, 20'th Jun 2025
Hims & Hers reported 2.4 million subscribers in Q1 FY25, a 38% YoY increase from 1.74 million in Q1 FY24. Personalized treatments now make up 58% of the subscriber base, with 70% of new users choosing
Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now?
01:11pm, Thursday, 19'th Jun 2025
HIMS accelerates global growth with ZAVA deal, AI investments and expanded access to obesity care treatments. However, macro challenges may hurt performance.
Hims & Hers: Outsized Subscription Growth Is Enviable - Premium Valuations
09:00am, Thursday, 19'th Jun 2025
The bulls have well defended Hims & Hers' recovery from the April 2025 bottom (near to our fair value estimates), thanks to the growing adoption of its personalized healthcare offerings. These have di
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
09:31am, Wednesday, 18'th Jun 2025
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
These 2 Growth Stocks Are No-Brainer Buys Right Now
04:00pm, Monday, 16'th Jun 2025
When it comes to investing, sometimes you want to take a big swing. After all, it's not always the number of winners in your portfolio that power your returns, but finding a few stocks that can be mas
2 Reasons To Double Down On Hims & Hers Ahead Of August
12:03pm, Monday, 16'th Jun 2025
I expected Hims & Hers' stock to break $50, and now I'm buckling up for another rally, with EMAs stacked bullishly at the moment. The company's partnership with Novo Nordisk and the ZAVA acquisition f
Hims & Hers: An Excellent Subscription Business
08:45pm, Saturday, 14'th Jun 2025
Hims & Hers offers a high-growth, recurring subscription telehealth business with strong user and revenue growth, expanding into multiple health segments. It is the market leader in telehealth easily
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 13'th Jun 2025
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
These 24 Stocks Are Ripe for a Short Squeeze
03:11pm, Thursday, 12'th Jun 2025
With the way negative stock market sentiment has piled up recently, short squeezes have generated some massive returns.
HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth
11:40am, Thursday, 12'th Jun 2025
Hims & Hers' 38.4% subscriber growth and $576.4 million online revenues highlight the power of its personalized subscription model.
Hims & Hers: The ZAVA Acquisition Catapults Growth In Europe's Weight-Loss Market
03:34am, Wednesday, 11'th Jun 2025
Hims & Hers Health's acquisition of ZAVA fast-tracks its entry into Europe's weight-loss market, expanding its subscriber base by 54%. The deal is attractively priced, non-dilutive, and leverages ZAVA
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Tuesday, 10'th Jun 2025
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $55.25, denoting a -2.83% change from the preceding trading day.
Bought $40,000 of Hims & Hers (HIMS) Stock on a YOLO – Is it Time to Sell?
11:12am, Tuesday, 10'th Jun 2025
Hims & Hers is an exciting stock in the telehealth sector, but as a growth stock, it's not for the faint of heart.
Hims & Hers says its weight-loss business can grow as US market changes
06:14am, Tuesday, 10'th Jun 2025
Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some analysts see a need for the online website to adjust to changing competition in
Why Hims & Hers Health (HIMS) Might be Well Poised for a Surge
01:20pm, Monday, 09'th Jun 2025
Hims & Hers Health (HIMS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
